supported by

Supported by grants from The Interministerial Science and Technology Committee SAF2005-05096); The Carlos III Health Institute, National Scientific Research, Development and Technological Innovation Program Health Investigation Resources, co-financed by The European Regional Development Fund (FIS10/00335, FIS13/02500, FIS16/00506, FIS19/00844, FIS22/01314); The European Union Horizon 2020 Research and Innovation program (EPIBRAIN project), funded by the Joint Programming Initiative ‘A Healthy Diet for a Healthy Life’ (ERA HDHL), JFA2 Nutrition and the Epigenome, Horizon 2020 grant agreement number 696300, with funding provided by The Spanish State Agency for Investigation (PCI2018-093098/AEI). Pere Virgili Health Research Institute (IISPV-2010/21); Biomedical Research Networking Center for the Pathophysiology of Obesity (CIBERobn); Agency for Management of University and Research grants, Generalitat de Catalunya (Support to Research Groups: 2009-1237, 2014-332, 2021-00336) and Italfarmaco S.A., Spain. Predoctoral research fellowships from the URV Martí-Franques program.